Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity

US10494380B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10494380-B2
Application numberUS-201615577795-A
CountryUS
Kind codeB2
Filing dateMay 27, 2016
Priority dateMay 29, 2015
Publication dateDec 3, 2019
Grant dateDec 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a novel compound having antiviral activity, especially HIV replication inhibitory activity and a medicament containing the same. The compound represented by the formula: wherein A 3 is CR 3A , CR 3A R 3B , N or NR 3C ; R 3A , R 3B , R 4A and R 4B are each independently a hydrogen atom, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, or substituted or unsubstituted non-aromatic carbocyclyl; R 3C is a hydrogen atom, substituted or unsubstituted alkyl, or substituted or unsubstituted non-aromatic carbocyclyl; ring T 1 is substituted or unsubstituted nitrogen-containing non-aromatic heterocycle; R 1 is a hydrogen atom, halogen, cyano, or substituted or unsubstituted alkyl; R 2 is each independently substituted or unsubstituted alkyl or the like: n is 1 or 2; R 3 is substituted or unsubstituted aromatic carbocyclyl or the like; R 4 is a hydrogen atom or a carboxy protecting group.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I′) or a pharmaceutically acceptable salt thereof, wherein A 3 is CR 3A , or N; R 3A is hydrogen or halogen; R 4A is halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, or substituted or unsubstituted non-aromatic carbocyclyl, where a substituent or substituents of R 4A are same or different 1 to 4 substituents selected from alkyloxy, hydroxy, halogen, haloalkyl, haloalkyloxy, amino, alkylamino, and aromatic carbocyclylalkyloxy; a ring T 1 is substituted or unsubstituted nitrogen-containing non-aromatic heterocycle, where a substituent or substituents of T 1 ring are each independently oxo, hydroxy, halogen, amino, alkylamino, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, —COR a1 , —SOR a2 , —SO 2 R a3 , or —NR a4 R a5 or same or different 1 to 4 substituents selected from R a , R b , and R c , where a substituent or substituents of the substituent or substituents on the T 1 ring are same or different 1 to 4 substituents selected from alkyl, alkenyl, alkynyl, alkyloxy, hydroxy, alkyloxy alkyl, hydroxyalkyl, halogen, haloalkyl, haloalkyloxy, amino, alkylamino, dialkylamino, trialkylsilyl, non-aromatic carbocycle amino, substituted or unsubstituted phenyl where a substituent or substituents are selected from alkyl, alkyloxy, hydroxy, and halogen, substituted or unsubstituted phenyloxy where a substituent or substituents are selected from alkyl, alkyloxy, hydroxy, and halogen, substituted or unsubstituted benzyloxy where a substituent or substituents are selected from alkyl, alkyloxy, hydroxy, and halogen, substituted or unsubstituted aromatic heterocyclyl where a substituent or substituents are selected from alkyl, alkyloxy, hydroxy, and halogen, substituted or unsubstituted non-aromatic heterocyclyl where a substituent or substituents are selected from alkyl, alkyloxy, hydroxy, and halogen, and non-aromatic heterocycle amino; R a is each independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted aromatic carbocyclyl, substituted or unsubstituted non-aromatic carbocyclyl, substituted or unsubstituted aromatic heterocyclyl, substituted or unsubstituted non-aromatic heterocyclyl, substituted or unsubstituted aromatic carbocyclylalkyl, substituted or unsubstituted non-aromatic carbocyclylalkyl, substituted or unsubstituted aromatic heterocyclylalkyl, substituted or unsubstituted non-aromatic heterocyclylalkyl, —COR a1 , —SOR a2 , —SO 2 R a3 , —CONR a4 R a5 , —CSNR a4 R a5 , —COCONR a4 R a5 , or —C(NR a6 )NR a4 R a5 , where a substituent or substituents of R a are same or different 1 to 4 substituents selected from alkyl, alkenyl, alkynyl, alkyloxy, hydroxy, alkyloxyalkyl, hydroxyalkyl, halogen, haloalkyl, haloalkyloxy, amino, alkylamino, dialkylamino, aminoalkyl, alkyloxyalkyl, alkylsulfonyl aminoalkyl, alkylcarbonylamino, alkylcarbonyl aminoalkyl, alkyloxyalkyloxycarbonylamino, alkylaminoalkyl, dialkyl aminoalkyl, amino alkyloxy, alkylamino alkyloxy, dialkylaminoalkyloxy, dialkylaminoalkyloxyalkyl, alkylcarbonylamino, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, benzyl, halogenated benzyl, aromatic carbocyclyl which is optionally substituted with halogen, alkyl, alkyloxy, cycloalkyl and/or haloalkyl, non-aromatic carbocyclyl which is optionally substituted with halogen, alkyl, alkyloxy, oxo and/or haloalkyl, aromatic heterocyclyl which is optionally substituted with halogen, alkyl, alkenyl, hydroxyalkyl, alkyloxy, cycloalkyl, non-aromatic carbocyclyl, non-aromatic heterocyclyl, and/or haloalkyl, non-aromatic heterocyclyl which is optionally substituted with halogen, alkyl, alkyloxy, oxo and/or haloalkyl, aromatic carbocyclylalkyl which is optionally substituted with halogen, alkyl, and/or haloalkyl, non-aromatic carbocycle which is optionally substituted with halogen, alkyl, and/or haloalkyl, aromatic heterocyclylalkyl which is optionally substituted with halogen, alkyl, and/or haloalkyl, non-aromatic heterocyclylalkyl which is optionally substituted with halogen, alkyl, and/or haloalkyl, non-aromatic heterocyclyl which is optionally substituted with alkylhalogen, non-aromatic carbocycle amino, non-aromatic heterocyclylalkyl which is optionally substituted with oxo, halogen, and/or alkyl, and trialkylsilyl; R a1 , R a2 and R a3 are each independently alkyl optionally substituted with one or more groups selected from Substituent Group A, alkenyl, alkyloxy, amino, aromatic carbocyclyl, non-aromatic carbocyclyl optionally substituted with one or more groups selected from Substituent Group B, aromatic heterocyclyl optionally substituted with one or more groups selected from the Substituent Group B, or non-aromatic heterocyclyl; the Substituent Group A is each independently halogen, amino, hydroxy, carboxy, oxo, monoalkyl amino, dialkyl amino, carbamoyl, monoalkyl carbamoyl, dialkyl carbamoyl, alkyloxy, haloalkyloxy, sulfamoyl, monoalkyl sulfamoyl, dialkyl sulfamoyl, alkyloxyalkyloxy, haloalkyloxyalkyloxy, alkylcarbonyl, alkylsulfonyl, alkylcarbonylamino, alkylcarbonyl(alkyl)amino, alkylsulfonylamino, alkylsulfonyl(alkyl)amino, trialkylsilyl, alkyl and/or halogeno aromatic carbocyclyl, non-aromatic carbocyclyl optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic heterocyclyl, non-aromatic heterocyclyl optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic carbocyclyloxy, non-aromatic carbocyclyloxy optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic heterocyclyloxy, or non-aromatic heterocyclyloxy optionally substituted with oxo, alkyl and/or halogen; the Substituent Group B is each independently halogen, amino, hydroxy, carboxy, oxo, monoalkyl amino, dialkyl amino, carbamoyl, monoalkyl carbamoyl, dialkyl carbamoyl, alkyl, haloalkyl, alkyloxy, haloalkyloxy, hydroxyalkyl, amino alkyl, monoalkyl amino alkyl, dialkyl amino alkyl, sulfamoyl, monoalkyl sulfamoyl, dialkyl sulfamoyl, alkyl oxy alkyl, alkyl oxy alkyl oxy, haloalkyloxyalkyl, haloalkyloxyalkyloxy, alkylcarbonylamino, alkylcarbonyl(alkyl)amino, alkylsulfonylamino, alkylsulfonyl(alkyl)amino, alkyl and/or halogeno aromatic carbocyclyl, non-aromatic carbocyclyl optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic heterocyclyl, non-aromatic heterocyclyl optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic carbocyclyloxy, non-aromatic carbocyclyloxy optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic heterocyclyloxy, non-aromatic heterocyclyloxy optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic carbocyclylalkyl, non-aromatic carbocyclylalkyl optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic heterocyclylalkyl, non-aromatic heterocyclylalkyl optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic carbocyclylalkyloxy, non-aromatic carbocyclylalkyloxy optionally substituted with oxo, alkyl and/or halogen, alkyl and/or halogeno aromatic heterocyclylalkyloxy, or non-aromatic heterocyclylalkyloxy optionally substituted with oxo, alkyl and/or halogen; R a4 and R a5 are each independently hydrogen, hydroxy, alkyl optionally substituted with one or more groups selected from the Substituent Group A, alkenyl, alkynyl, alkyloxy, aromatic carbocyclyl optionally substituted with amino or halogen, non-aromatic carbocyclyl optionally substituted with one or more groups selected from the Substituent Group B, aromatic heterocyclyl optionally substituted with one or more groups selected from the Substituent Group B, or non-aromatic heterocyclyl; R a6 is

Assignees

Inventors

Classifications

  • C07D513/06Primary

    Peri-condensed systems · CPC title

  • C07D487/06Primary

    Peri-condensed systems · CPC title

  • for HIV · CPC title

  • Antivirals · CPC title

  • having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10494380B2 cover?
The present invention provides a novel compound having antiviral activity, especially HIV replication inhibitory activity and a medicament containing the same. The compound represented by the formula: wherein A 3 is CR 3A , CR 3A R 3B , N or NR 3C ; R 3A , R 3B , R 4A and R 4B are each independently a hydrogen atom, halogen, cyano, substituted or unsubstituted alky…
Who is the assignee on this patent?
Shionogi & Co
What technology area does this patent fall under?
Primary CPC classification C07D513/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).